HIGH-RISK TRANSIENT ISCHEMIC ATTACK
Clinical trials for HIGH-RISK TRANSIENT ISCHEMIC ATTACK explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK TRANSIENT ISCHEMIC ATTACK trials appear
Sign up with your email to follow new studies for HIGH-RISK TRANSIENT ISCHEMIC ATTACK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could cut stroke risk for High-Risk patients
Disease control Not yet recruitingThis study tests whether adding a drug called Tafolecimab to standard cholesterol-lowering therapy can reduce the risk of another stroke in people who have had a recent stroke or mini-stroke and have high levels of Lp(a), a type of fat in the blood. About 242 participants will re…
Matched conditions: HIGH-RISK TRANSIENT ISCHEMIC ATTACK
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a cheap blood thinner cut stroke risk in africa?
Prevention Not yet recruitingThis study tests whether the drug cilostazol can prevent recurrent strokes and heart problems in 1100 recent stroke survivors in Ghana. Participants take either cilostazol or a placebo twice daily for 24 months. The goal is to see if this affordable drug, already used in Asia, ca…
Matched conditions: HIGH-RISK TRANSIENT ISCHEMIC ATTACK
Phase: PHASE3 • Sponsor: Northern California Institute of Research and Education • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC